shiba inu The community continues to await the release of the Tier-2 network, Shibarium. The network was normally expected to air in Q3 but the date is not clear. According to the team’s statements, Shibarium will be ready by the end of this year. BONNET reacted positively to this development.
BONE, which is included in the Shiba Inu ecosystem, will play a critical role in this network. According to the team’s statements, BONE will be the token used by Tier-2 validators.
Koinfinans.com As we have reported, BONE issuance stopped at 230 million. Initial plans were to print 250 million copies. It has been decided that 20 million tokens will be used for validators.
shibarium As its launch approaches, interest in BONE is also increasing. Shibarium is not only trending on Twitter, but the token price is also rising.
BONE rose 48.5% in the last 14 days and 37.1% in the previous week.
With the increasing interest, many exchanges started to list BONE on their platforms. These firms include Now Wallet, UpHold, and SunCrypto.
Although the price of BONE has increased, there is a 17.57% drop in the trading volume of the token. The increase in price and the decrease in volume also created an expectation that the price will reverse rather than reverse.
At the time of reporting, BONE was trading at $0.981872.
Will Shibarium and BONE Change Things?
It is expected that Shibarium will increase speeds while reducing transaction costs. shiba inu With the transition to its own network, it will cease to be an ERC-20 token.
With Shibarium, there is also the possibility of an increase in new use cases for BONE and SHIB. In addition, there is the possibility of burning trillions of tokens with the Layer-2 solution.
You can follow the current price action here.
Disclaimer: What is written here is not investment advice. Cryptocurrency investments are high-risk investments. Every investment decision is under the individual’s own responsibility. Finally, Koinfinans and the author of this content cannot be held responsible for personal investment decisions.